Advertisement

Neuro-Urology pp 135-151 | Cite as

Multiple System Atrophy

  • Ryuji Sakakibara
Chapter

Abstract

Urinary dysfunction is a prominent autonomic feature in patients with MSA, and it is more common (above 90%) and occurs earlier than postural hypotension in this disorder. Since the clinical features of MSA may mimic those of IPD, a distinctive pattern of urinary dysfunction in both disorders is worth looking at. In contrast to IPD, MSA patients have more marked urinary dysfunction, which consists of both urgency incontinence and post-void residuals >100 ml. Videourodynamic and sphincter EMG analyses are important tools for understanding the extent of these dysfunctions and for determining both the diagnosis and management of the disorders. The common finding in both disorders is bladder overactivity, which accounts for urinary urgency and frequency. However, detrusor-sphincter dyssynergia, open bladder neck at the start of bladder filling (internal sphincter denervation), and neurogenic sphincter EMG (external sphincter denervation) are all characteristics of MSA. These features may reflect pathological lesions in the basal ganglia, pontine tegmentum, raphe, intermediolateral cell column, and sacral Onuf’s nuclei. During the course of the disease, the pathophysiological balance shifts from central to peripheral, with bladder emptying disorder predominating. Since MSA is a progressive disorder and impaired detrusor contractility is common, it is important to avoid inappropriate urological surgery in patients with MSA. A conservative approach with medical measures includes anticholinergics for urinary urgency and frequency, desmopressin for nocturnal polyuria, uro-selective alpha-blockers and cholinergic stimulants for voiding difficulty, and CIC for large PVR.

Keywords

Multiple system atrophy Urinary dysfunction Parkinson’s disease Urgency incontinence Urinary retention Urodynamics Sphincter electromyography Onuf’s nucleus Clean intermittent catheterization 

References

  1. 1.
    Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotinic sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1969;32:28–34.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Adams RD, van Bogaert L, Eecken HV. Striato–nigral degeneration. J Neuropathol Exp Neurol. 1964;23:584–608.PubMedGoogle Scholar
  3. 3.
    Dejerine J, Thomas A. L’atrophie olivo-ponto-cérébelleuse. Nouvelle Iconographie de la Salpêtriére. 1900;13:30–70.Google Scholar
  4. 4.
    Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension; a clinical-pathologic study. Arch Neurol. 1960;2:511–27.CrossRefPubMedGoogle Scholar
  5. 5.
    Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy–Drager syndrome). J Neurol Sci. 1989;94:79–100.CrossRefPubMedGoogle Scholar
  6. 6.
    Ahmed Z, Asi YT, Sailer A, et al. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol. 2012;38:4–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Fernagut PO, Tison F. Animal models of multiple system atrophy. Neuroscience. 2012;211:77–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–6.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology. 1996;46:1470.CrossRefGoogle Scholar
  10. 10.
    Chandiramani VA, Palace J, Fowler CJ. How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol. 1997;80:100–4.CrossRefPubMedGoogle Scholar
  11. 11.
    Yamamoto T, Sakakibara R, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy. Mov Disord. 2009;24:972–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21:167–78.CrossRefPubMedGoogle Scholar
  13. 13.
    Sakakibara R, Hattori T, Uchiyama T, et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy; which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry. 2000;68:65–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Wenning GK, Ben Shlomo Y, Magalhaes M, et al. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain. 1994;117:835–45.CrossRefPubMedGoogle Scholar
  15. 15.
    Gilman S, May SJ, Shults CW, et al. The north American multiple system atrophy study group. J Neural Transm. 2005;112:1687–94.CrossRefPubMedGoogle Scholar
  16. 16.
    Kirchhof K, Apostolidis AN, Mathias CJ, et al. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res. 2003;15:293–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Christmas TJ, Chapple CR, Lees AJ, et al. Role of subcutaneous apomorphine in parkinsonian voiding dysfunction. Lancet. 1998;2:1451–3.Google Scholar
  18. 18.
    Fitzmaurice H, Fowler CJ, Richards D, et al. Micturition disturbance in Parkinson’s disease. Br J Urol. 1985;57:652–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Sakakibara R, Hattori T, Uchiyama T, et al. Videourodynamic and sphincter motor unit potential analyses in Parkinson’s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry. 2001;71:600–6.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Berger Y, Salinas JM, Blaivas JG. Urodynamic differentiation of Parkinson disease and the Shy–Drager syndrome. Neurourol Urodyn. 1990;9:117–21.CrossRefGoogle Scholar
  21. 21.
    Stocchi F, Carbone A, Inghilleri M, et al. Urodynamic and neurophysiological evaluation in Parkinson’s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry. 1997;62:507–11.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Sand PK, Bowen LW, Ostergard DR. Uninhibited urethral relaxation; an unusual cause of incontinence. Obstet Gynecol. 1986;68:645–8.PubMedGoogle Scholar
  23. 23.
    de Groat WC, Booth AM, Yoshimura N. Neurophysiology of micturition and its modification in animal models of human disease. In: Maggi CA, editor. The autonomic nervous system: nervous control of the urogenital system, vol. 3. London: Harwood Academic Publishers; 1993. p. 227–90.Google Scholar
  24. 24.
    Yoshimura N, Mizuta E, Kuno S, et al. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by MPTP. Neuropharmacology. 1993;32:315–21.CrossRefPubMedGoogle Scholar
  25. 25.
    Sakakibara R, Fowler CJ. Cerebral control of bladder, bowel, and sexual function and effects of brain disease. In: Fowler CJ, editor. Neurology of bladder, bowel, and sexual function. Boston: Butterworth-Heinemann; 1999. p. 229–43.Google Scholar
  26. 26.
    Sakakibara R, Nakazawa K, Uchiyama T, et al. Micturition-related electrophysiological properties in the substantia nigra pars compacta and the ventral tegmental area in cats. Auton Neurosci. 2002;102:30–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Yamamoto T, Sakakibara R, Hashimoto K, et al. Striatal dopamine level increases in the urinary storage phase in cats: an in vivo microdialysis study. Neuroscience. 2005;135:299–303.CrossRefPubMedGoogle Scholar
  28. 28.
    Aswal BS, Berkley KJ, Hussain I, et al. Brain responses to changes in bladder volume and urge to void in healthy men. Brain. 2001;124:369–77.CrossRefGoogle Scholar
  29. 29.
    Kavia RBC, Dasgupta R, Fowler CJ. Functional imaging and the central control of the bladder. J Comp Neurol. 2005;493:27–32.CrossRefPubMedGoogle Scholar
  30. 30.
    Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, Mathias CJ, editors. Autonomic failure. 3rd ed. Oxford: Oxford Medical Publications; 1992. p. 564–85.Google Scholar
  31. 31.
    Benarroch EE, Schmeichel AM. Depletion of corticotrophin-releasing factor neurons in the pontine micturition area in multiple system atrophy. Ann Neurol. 2001;50:640–5.CrossRefPubMedGoogle Scholar
  32. 32.
    Benarroch EE, Schmeichel AM, Low PA, et al. Involvement of medullary serotonergic groups in multiple system atrophy. Ann Neurol. 2004;55:418–22.CrossRefPubMedGoogle Scholar
  33. 33.
    Fujita T, Doi M, Ogata T, et al. Cerebral cortical pathology of sporadic olivopontocerebellar atrophy. J Neurol Sci. 1993;116:41–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Andrew J, Nathan PW. Lesions of the anterior frontal lobes and disturbances of micturition and defaecation. Brain. 1964;87:233–62.CrossRefPubMedGoogle Scholar
  35. 35.
    Ito T, Sakakibara R, Nakazawa K, et al. Effects of electrical stimulation of the raphe area on the micturition reflex in cats. Neuroscience. 2006;142(4):1273–80. [Epub ahead of print] PMID: 16996219CrossRefPubMedGoogle Scholar
  36. 36.
    Nishizawa O, Ebina K, Sugaya K, et al. Effect of cerebellectomy on reflex micturition in the decerebrate dog as determined by urodynamic evaluation. Urol Int. 1989;44:152–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Sakakibara R, Uchida Y, Uchiyama T, et al. Reduced cerebellar vermis activation in response to micturition in multiple system atrophy; 99mTc-labeled ECD SPECT study. Eur J Neurol. 2004;11:705–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Ito T, Sakakibara R, Yasuda K, et al. Incomplete emptying and urinary retention in multiple system atrophy: when does it occur and how do we manage it? Mov Disord. 2006;21(6):816–23. [Epub ahead of print] PMID: 16511861CrossRefPubMedGoogle Scholar
  39. 39.
    Abrams P. Objective evaluation of bladder outlet obstruction. Br J Urol. 1995;76(Suppl 1):11–5.PubMedGoogle Scholar
  40. 40.
    Shäfer W. Principles and clinical application of advanced urodynamic analysis of voiding dysfunction. Urol Clin North Am. 1990;17:553–66.Google Scholar
  41. 41.
    Sakakibara R, Fowler CJ, Hattori T, et al. Pressure-flow study as an evaluating method of neurogenic urethral relaxation failure. J Auton Nerv Syst. 2000;80:85–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Blaivas JG, Sinha HP, Zayed AAH, et al. Detrusor-sphincter dyssynergia; a detailed electromyographic study. J Urol. 1981;125:545–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Yamamoto T, Sakakibara R, Uchiyama T, et al. Neurological diseases that cause detrusor hyperactivity with impaired contractile function. Neurourol Urodyn. 2006;25:356–60.CrossRefPubMedGoogle Scholar
  44. 44.
    Yamanishi T, Yasuda K, Sakakibara R, et al. The effectiveness of terazosin, an al-blocker, on bladder neck obstruction as assessed by urodynamic hydraulic energy. BJU Int. 2000;85:249–53.CrossRefPubMedGoogle Scholar
  45. 45.
    Sakuta M, Nakanishi T, Toyokura Y. Anal muscle electromyograms differ in amyotrophic lateral sclerosis and Shy–Drager syndrome. Neurology. 1978;28:1289–93.CrossRefPubMedGoogle Scholar
  46. 46.
    Sakakibara R, Uchiyama T, Yamanishi T, et al. Sphincter EMG as a diagnostic tool in autonomic disorders. Clin Auton Res. 2009;19:20–31.CrossRefPubMedGoogle Scholar
  47. 47.
    Yamamoto T, Sakakibara R, Uchiyama T, et al. Receiver operating characteristic analysis of sphincter electromyography for parkinsonian syndrome. Neurourol Urodyn. 2012;31:1128–34.CrossRefPubMedGoogle Scholar
  48. 48.
    Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol. 1994l;151:1336–41.CrossRefPubMedGoogle Scholar
  49. 49.
    Ozawa T, Oyanagi K, Tanaka H, et al. Suprachiasmal nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine vasopressin secretion into plasma. J Neurol Sci. 1998;154:116–21.CrossRefPubMedGoogle Scholar
  50. 50.
    Podnar S, Fowler CJ. Sphincter electromyography in diagnosis of multiple system atrophy: technical issues. Muscle Nerve. 2004;29:151–6.CrossRefPubMedGoogle Scholar
  51. 51.
    Yamamoto T, Sakakibara R, Uchiyama T, et al. When is Onuf’s nucleus involved in multiple system atrophy? A sphincter electromyography study. J Neurol Neurosurg Psychiatry. 2005;76:1645–8.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Paviour DC, Williams DC, Fowler CJ, et al. Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis. Mov Disord. 2005;20:1425–30.CrossRefPubMedGoogle Scholar
  53. 53.
    Takahashi O, Sakakibara R, Tsunoyama K, et al. Do sacral/peripheral lesions contribute to detrusor-sphincter dyssynergia? LUTS. 2012;4:126–9.PubMedGoogle Scholar
  54. 54.
    Pramstaller PP, Wenning GK, Smith SJM, et al. Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995;580:618–21.CrossRefGoogle Scholar
  55. 55.
    Morgan C, Nadelhaft I, de Groat WC. Location of bladder preganglionic neurones within the sacral parasympathetic nucleus of the cat. Neurosci Lett. 1979;14:189–94.CrossRefPubMedGoogle Scholar
  56. 56.
    Skehan AM, Downie JW, Awad SA. The pathophysiology of contractile activity in the chronic decentralized feline bladder. J Urol. 1993;149:1156–64.CrossRefPubMedGoogle Scholar
  57. 57.
    Lapides J, Friend CR, Ajemian EP, et al. Denervation supersensibility as a test for neurogenic bladder. Surg Gynecol Obstet. 1962;114:241–4.Google Scholar
  58. 58.
    Ozawa T, Tanaka H, Nakano R, et al. Nocturnal decrease in vasopressin secretion into plasma in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry. 1999;67:542–5.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Mathias CJ, Fosbraey P, DaCosta DF, et al. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. BMJ. 1986;293:353–6.CrossRefPubMedGoogle Scholar
  60. 60.
    Wilcox CS, Aminoff MJ, Penn W. Basis of nocturnal polyuria in patients with autonomic failure. J Neurol Neurosurg Psychiatry. 1974;37:677.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Donnellan CA, Fook L, McDonald P, et al. Oxybutynin and cognitive dysfunction. BMJ. 1997;315:1363–4.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Sakakibara R, Hattori T, Uchiyama T, et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst. 2000;79:191–5.CrossRefPubMedGoogle Scholar
  63. 63.
    Sakakibara R, Uchiyama T, Asahina M, et al. Amezinium metilsulfate, a sympathomimetic agent, may increase the risk of urinary retention in multiple system atrophy. Clin Auton Res. 2003;13(1):51–3.CrossRefPubMedGoogle Scholar
  64. 64.
    Schwinn DA. Novel role for alpha 1-adrenergic receptor subtypes in lower urinary tract symptoms. BJU Int. 2000;86(Suppl 2):11–22.CrossRefPubMedGoogle Scholar
  65. 65.
    Yamanishi T, Yasuda K, Kamai T, et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol. 2004;11:88–96.CrossRefPubMedGoogle Scholar
  66. 66.
    Sandroni P, Opfer-Gehrking TL, Singer W, et al. Pyridostigmine for treatment of neurogenic orthostatic hypertension. A follow-up survey study. Clin Auton Res. 2005;15:51–3.CrossRefPubMedGoogle Scholar
  67. 67.
    Yamamoto T, Sakakibara R, Yamanaka Y, et al. Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug? Clin Auton Res. 2006;16:296–8.CrossRefPubMedGoogle Scholar
  68. 68.
    Yamamoto M. Pergolide improves neurogenic bladder in patients with Parkinson’s disease. Movem Dis. 1997;12(Supp1):328.Google Scholar
  69. 69.
    Kuno S, Mizutaa E, Yamasakia S, et al. Effects of pergolide on nocturia in Parkinson’s disease: three female cases selected from over 400 patients. Parkinsonism Relat Disord. 2004;10:181–7.CrossRefPubMedGoogle Scholar
  70. 70.
    Uchiyama T, Sakakibara R, Yamanishi T, et al. Short-term effect of l-dopa on the micturitional function in patients with Parkinson’s disease. Mov Disord. 2003;18:573–8.CrossRefPubMedGoogle Scholar
  71. 71.
    Brusa L, Petta F, Pisani A, et al. Central acute D2 stimulation worsens bladder function in patients with mild Parkinson’s disease. J Urol. 2006;175:202–6.CrossRefPubMedGoogle Scholar
  72. 72.
    Sakakibara R, Matsuda S, Uchiyama T, et al. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res. 2003;13:106–8.CrossRefPubMedGoogle Scholar
  73. 73.
    Uchiyama T, Sakakibara R, Asahina M, et al. Post-micturitional hypotension in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry. 2005;76:186–90.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Coon EA, Sletten DM, Suarez MD, et al. Clinical features and autonomic testing predict survival in multiple system atrophy. Brain. 2015;138:3623–31.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Figueroa JJ, Singer W, Parsaik A, et al. Multiple system atrophy: prognostic indicators of survival. Mov Disord. 2014;29:1151–7.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Sakakibara R, Panicker J, Finazzi-Agro E, et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn. 2015.  https://doi.org/10.1002/nau.22764. [Epub ahead of print]

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of NeurologyInternal Medicine, Sakura Medical Center, Toho UniversitySakuraJapan

Personalised recommendations